We next asked if recombinant K-RasT50I has a reduced rate of intrinsic GTP hydrolysis or impaired GAP sensitivity, as commonly observed in oncogenic and Rasopathy K-Ras mutant proteins (1, 8, 9, 11, 32). This evidence concerns the gene KRAS and RASopathy.